Workforce

Delaware psychiatry residency highlights TMS training

TMS Therapy Delaware editorial teamSource-backed reportingSeptember 26, 20262 min read
Editorial image for Delaware psychiatry residency highlights TMS training
What changed

ChristianaCare's Delaware psychiatry residency program highlights direct resident exposure to ECT and TMS in training for treatment-resistant psychiatric care.

Residency program describes neuromodulation exposure

According to the ChristianaCare Psychiatry Residency Program’s “Message from the Associate Program Directors,” its Delaware psychiatry residency program includes training in advanced neuromodulation techniques. The program specifically highlights electroconvulsive therapy, also called ECT, and transcranial magnetic stimulation, or TMS.

The source states that residents receive direct clinical exposure to these approaches. It presents this exposure as part of training related to treatment-resistant psychiatric care.

TMS is named among advanced techniques

ChristianaCare’s residency message identifies TMS as one of the advanced neuromodulation techniques included in the program’s training. The source places TMS alongside ECT in describing the clinical experience available to psychiatry residents in Delaware.

The message does not provide further details about the structure, duration, or number of residents involved in this training. It also does not describe particular patient populations, treatment protocols, or program outcomes.

Workforce relevance

The residency message indicates that psychiatry trainees can gain direct exposure to TMS and ECT during their Delaware-based training. According to the source, that exposure is connected to care for treatment-resistant psychiatric conditions.

Training opportunities involving advanced neuromodulation may be relevant to the future psychiatric workforce, but the source does not make claims about how many clinicians will provide these services after residency or where they may practice.

Source scope

This item is based on the ChristianaCare Psychiatry Residency Program’s message from its associate program directors. The message highlights resident training and clinical exposure; it is not a policy announcement, funding report, or statement about insurance coverage.

The source does not provide information about treatment availability, costs, referral requirements, or access barriers for Delaware patients.

What this means for Delaware patients

For people looking for treatment locally, the directory lists 22 published clinics in Delaware. ChristianaCare’s residency message indicates that TMS is part of advanced neuromodulation training for psychiatry residents in the state, though it does not address where patients can receive care.

This is general information, not medical advice.

More Delaware reporting on workforce.

This report is educational and is not medical advice. Coverage, availability and eligibility can change; verify details with the named source or your care team.

Related Delaware updates

Find a Provider